Zhiwei Li
Key Laboratory Of Chemical Biology And Traditional Chinese Medicine Research, Key Laboratory Of The Assembly And Application Of Organic Functional Molecules Of Hunan Province
Changsha, 410081, China
Changsha, 410081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Substrate-Controlled Palladium(II)-Catalyzed Regiodivergent Oxypalladation/C-H Annulation of Alkynylaryl Carboxylates with o-Bromobenzoic Acids.
Journal: Organic letters
Published: July 10, 2025
KCTD10 inhibits lung cancer metastasis and angiogenesis via ubiquitin-mediated β-catenin degradation.
Journal: Frontiers in immunology
Published: May 17, 2025
Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 31, 2025
Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10.
Journal: Cell death & disease
Published: November 12, 2024
A Cascade C(sp3)-H Annulation Involving C(alkyl),C(alkyl)-Palladacycle Intermediates.
Journal: Angewandte Chemie (International ed. in English)
Published: July 01, 2024
Norbornene Derivatives-Controlled Palladium-Catalyzed Divergent Synthesis of Dibenzo[a,c]cycloheptenones and Fluorenones from Aryl Iodides and α-Oxocarboxylic Acids.
Journal: Organic letters
Published: January 18, 2024
MiR-93 alleviates DEHP plasticizer-induced neurotoxicity by negatively regulating TNFAIP1 and inhibiting ubiquitin-mediated degradation of CK2β.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: February 23, 2023
Epigenetically modified AP-2α by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression.
Journal: Cell death & disease
Published: December 31, 2022
Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs.
Journal: Biomaterials advances
Published: October 29, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026